Irisquinone

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIrisquinone
Drug Alias Name鸢尾醌马蔺子甲素鸢尾酮安卡SAN-5201 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulantsRadiosensitizersApoptosis inducers
TargetsNot applicable
Therapy Area/IndicationsLung NeoplasmsHead and Neck NeoplasmsEsophageal Neoplasms
Global Approved IndicationsLung NeoplasmsHead and Neck NeoplasmsEsophageal Neoplasms
Approved Indications in ChinaLung NeoplasmsHead and Neck NeoplasmsEsophageal Neoplasms
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShandong Xinhua Pharmaceutical Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Xinhua Pharmaceutical Company Ltd
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsHead and Neck NeoplasmsEsophageal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL01
Related LinksN/A